Avmapki (avutometinib) - Verastem
Krazati (adagrasib) - BMS
Datroway (datopotamab deruxtecan-dlnk) - Daiichi Sankyo, AstraZeneca
Nerlynx (neratinib) - Puma
Fakzynja (defactinib) - Verastem
Balversa (erdafitinib) - J&J
Revuforj (revumenib) - Syndax Pharma
Herceptin (trastuzumab) - Roche
fulvestrant - Generic mfg.
Lumakras (sotorasib) - Amgen
Modeyso (dordaviprone) - Jazz
https://www.abstractsonline.com/pp8/#!/21436/presentation/3729
 
Sarah Phillips Suehnholz1; Ritika Kundra1; Moriah Heller Nissan2; Calvin Lu1; Nicole Fernandez1; Kelly Cavender1; Kinisha Gala1; Benjamin Preiser1; Reshma Ramaiah1; John Konecny1; Xiang Li1; Subhiksha Nandakumar3; Kseniya Petrova-Drus1; Mark Ewalt1; Nikita Mehta1; Yonina R. Murciano-Goroff1; James Du1; Anoop Balakrishnan Rema1; Aijazuddin Syed1; A. Rose Brannon1; Ahmet Dogan1; Diana Mandelker1; Zsofia K. Stadler1; Alexander Drilon1; David B. Solit1; Ross L. Levine4; Maria E. Arcila1; Marc Ladanyi1; Michael F. Berger1; Jianjiong Gao1; Nikolaus Schultz1; Debyani Chakravarty1
 
Mar 18, 2026
 
Prev Next